NRG1-dependent activation of HER3 induces primary resistance to trastuzumab in HER2-overexpressing breast cancer cells

Liuting Yang(Shanxi Medical University), Qin Li(Guangdong University of Technology)
International Journal of Oncology
September 21, 2017
Cited by 83


Related Papers